Passa al contenuto
Merck
Tutte le immagini(3)

Documenti

SAB4200465

Sigma-Aldrich

Anti-Kindlin-1 antibody, Mouse monoclonal

clone KN-4, purified from hybridoma cell culture

Sinonimo/i:

Monoclonal Anti-C20orf42, Monoclonal Anti-DTGCU2, Monoclonal Anti-FERMT1 URP1, Monoclonal Anti-KIND1, Monoclonal Anti-Kindlin-1 antibody produced in mouse, Monoclonal Anti-UNC112A, Monoclonal Anti-fermitin family member 1

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
12352203
NACRES:
NA.41

Origine biologica

mouse

Coniugato

unconjugated

Forma dell’anticorpo

purified from hybridoma cell culture

Tipo di anticorpo

primary antibodies

Clone

KN-4, monoclonal

Forma fisica

buffered aqueous solution

PM

antigen ~50 kDa (isoform 4)
antigen ~60 kDa (isoform 2)
antigen ~77 kDa (isoform 1)

Reattività contro le specie

mouse, human

Concentrazione

~1.0 mg/mL

tecniche

indirect immunofluorescence: 2.5-5.0 μg/mL using SW-620 cells
western blot: 1.0-2.0 μg/mL using SW-48 total cell extracts

Isotipo

IgG1

N° accesso UniProt

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

modifica post-traduzionali bersaglio

unmodified

Informazioni sul gene

human ... FERMT1(55612)
mouse ... Fermt1(241639)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

Kindlin-1 is coded by FERMT1 (fermitin family member 1) gene. It is a focal adhesion protein, expressed in the skin and intestine. FERMT1 is located on human chromosome 20p.12.3.

Immunogeno

synthetic peptide corresponding to a sequence close to the N-terminus of human Kindlin-1, conjugated to KLH. The isotype is determined by ELISA using Mouse Monoclonal Antibody Isotyping Reagents (Sigma ISO-2).

Applicazioni

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Western Blotting (1 paper)
Monoclonal Anti-Kindlin-1 antibody has been used in immunohistochemistry, immunofluorescence staining and western blotting.

Azioni biochim/fisiol

Kindlin-1 protein, coded by FERMT1 gene modulates keratinocyte electrotaxis. It participates in the initiation of the integrin family of extracellular matrix receptors. FERMT1 maintains the lamellipodial protrusions at the time of electrotaxis. Mutations in kindlin-1 results in Kindler syndrome (KS).

Stato fisico

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Esclusione di responsabilità

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Motore di ricerca dei prodotti.

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 2

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Case of Kindler syndrome resulting from mutation in the FERMT1 gene
Wada MM, et al.
The Journal of Dermatology, 39(12), 1057-1058 (2012)
Kindlin-2 controls TGF-beta signalling and Sox9 expression to regulate chondrogenesis
Wu CJ, et al.
Nature Communications, 6(4), 7531-7531 (2015)
Kindlin-1 contributes to EGF-induced re-epithelialization in skin wound healing
Shen CS, et al.
International Journal of Molecular Medicine, 39(4), 949-959 (2017)
Kindler Syndrome
Harper's Textbook of Pediatric Dermatology, 1(11), 119-111 (2011)
Congcong Shen et al.
International journal of molecular medicine, 39(4), 949-959 (2017-03-16)
The commercial use of epidermal growth factor (EGF) is extensive and has been shown to be effective for skin wound healing in clinical practice. There is evidence to indicate that the topical administration of EGF significantly accelerates re-epithelialization by promoting keratinocyte

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.